This list is an analysis based on recent market events. It's not an investment recommendation.
Level Bio AB (publ) manufactures and distributes cutting-edge and diagnostic solutions in the Nordic region and internationally. It develops and manufactures diagnostic kits for the clinical market, as well as act as a distributor and full service partner to molecular biology labs in the Nordics. The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024. Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden.
FAQs
What is Level Bio AB stock price today?▼
The current price of 4MB.F is €0.01 EUR — it has increased by +16.67% in the past 24 hours. Watch Level Bio AB stock price performance more closely on the chart.
What is Level Bio AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Frankfurt Exchange exchange Level Bio AB stocks are traded under the ticker 4MB.F.
Is Level Bio AB stock price growing?▼
4MB.F stock has risen by +0% compared to the previous week, the month change is a -8.7% fall, over the last year Level Bio AB has showed a -58.82% decrease.
What is Level Bio AB market cap?▼
Today Level Bio AB has the market capitalization of 718,189.5
What is Level Bio AB revenue for the last year?▼
Level Bio AB revenue for the last year amounts to 2.97M EUR.
What is Level Bio AB net income for the last year?▼
4MB.F net income for the last year is -323,008.28 EUR.
How many employees does Level Bio AB have?▼
As of November 1, 2026, the company has 10 employees.
In which sector is Level Bio AB located?▼
Level Bio AB operates in the Health & Wellness sector.
When did Level Bio AB complete a stock split?▼
Level Bio AB has not had any recent stock splits.
Where is Level Bio AB headquartered?▼
Level Bio AB is headquartered in Stockholm, Germany.